PeopleBio Statistics

Total Valuation

PeopleBio has a market cap or net worth of KRW 55.89 billion. The enterprise value is 58.27 billion.

Market Cap	55.89B
Enterprise Value	58.27B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

PeopleBio has 21.17 million shares outstanding. The number of shares has increased by 31.10% in one year.

Current Share Class	21.17M
Shares Outstanding	21.17M
Shares Change (YoY)	+31.10%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	10.48%
Owned by Institutions (%)	n/a
Float	17.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.98
PB Ratio	7.33
P/TBV Ratio	10.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.34
EV / Sales	15.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.30

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 1.21.

Current Ratio	1.03
Quick Ratio	0.56
Debt / Equity	1.21
Debt / EBITDA	n/a
Debt / FCF	-0.84
Interest Coverage	-10.75

Financial Efficiency

Return on equity (ROE) is -89.23% and return on invested capital (ROIC) is -36.78%.

Return on Equity (ROE)	-89.23%
Return on Assets (ROA)	-26.30%
Return on Invested Capital (ROIC)	-36.78%
Return on Capital Employed (ROCE)	-109.32%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	0.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.94% in the last 52 weeks. The beta is 0.64, so PeopleBio's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-0.94%
50-Day Moving Average	2,721.20
200-Day Moving Average	3,329.58
Relative Strength Index (RSI)	42.37
Average Volume (20 Days)	250,050

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PeopleBio had revenue of KRW 3.73 billion and -10.91 billion in losses. Loss per share was -502.24.

Revenue	3.73B
Gross Profit	1.33B
Operating Income	-11.50B
Pretax Income	-12.17B
Net Income	-10.91B
EBITDA	-9.81B
EBIT	-11.50B
Loss Per Share	-502.24

Full Income Statement

Balance Sheet

The company has 6.39 billion in cash and 9.25 billion in debt, giving a net cash position of -2.86 billion or -135.04 per share.

Cash & Cash Equivalents	6.39B
Total Debt	9.25B
Net Cash	-2.86B
Net Cash Per Share	-135.04
Equity (Book Value)	7.62B
Book Value Per Share	382.52
Working Capital	521.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.91 billion and capital expenditures -78.60 million, giving a free cash flow of -10.99 billion.

Operating Cash Flow	-10.91B
Capital Expenditures	-78.60M
Free Cash Flow	-10.99B
FCF Per Share	-519.11

Full Cash Flow Statement

Margins

Gross margin is 35.61%, with operating and profit margins of -308.22% and -292.46%.

Gross Margin	35.61%
Operating Margin	-308.22%
Pretax Margin	-326.22%
Profit Margin	-292.46%
EBITDA Margin	-262.87%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PeopleBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.10%
Shareholder Yield	-31.10%
Earnings Yield	-19.53%
FCF Yield	-19.66%

Stock Splits

The last stock split was on October 23, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 23, 2023
Split Type	Forward
Split Ratio	1.2

Scores

PeopleBio has an Altman Z-Score of -3.12. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.12
Piotroski F-Score	n/a